Evaluation and management of dyspepsia - current perspectives.
作者信息
Goh Kl
机构信息
MBBS (Mal), FRCP (Glasg), FRCP (London), MD, FACG, Professor of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
出版信息
Malays Fam Physician. 2007 Apr 30;2(1):2-7. eCollection 2007.
Abstract
摘要
相似文献
1
Evaluation and management of dyspepsia - current perspectives.
Malays Fam Physician. 2007 Apr 30;2(1):2-7. eCollection 2007.
2
Review article: the continuing dilemma of dyspepsia.
Aliment Pharmacol Ther. 2001 Jun;15 Suppl 1:6-9. doi: 10.1046/j.1365-2036.2001.00108.x.
3
Thailand Dyspepsia Guidelines: 2018.
J Neurogastroenterol Motil. 2019 Jan 31;25(1):15-26. doi: 10.5056/jnm18081.
4
Nonulcer dyspepsia: current approaches to diagnosis and management.
Am Fam Physician. 1993 May 1;47(6):1407-16.
5
Management of functional dyspepsia: Unsolved problems and new perspectives.
World J Gastroenterol. 2005 Nov 14;11(42):6577-81. doi: 10.3748/wjg.v11.i42.6577.
6
Current guidelines for dyspepsia management.
Dig Dis. 2008;26(3):225-30. doi: 10.1159/000121351. Epub 2008 May 6.
7
Management of uninvestigated and functional dyspepsia: a Working Party report for the World Congresses of Gastroenterology 1998.
Aliment Pharmacol Ther. 1999 Sep;13(9):1135-48. doi: 10.1046/j.1365-2036.1999.00584.x.
8
[Management of patients with dyspepsia].
Vnitr Lek. 2014 Jul-Aug;60(7-8):657-63.
9
Insights into the evaluation and management of dyspepsia: recent developments and new guidelines.
Therap Adv Gastroenterol. 2018 Oct 30;11:1756284818805597. doi: 10.1177/1756284818805597. eCollection 2018.
10
Dyspepsia: management guidelines for the millennium.
Gut. 2002 May;50 Suppl 4(Suppl 4):iv72-8; discussion iv79. doi: 10.1136/gut.50.suppl_4.iv72.
引用本文的文献
1
Comparison of clinical symptoms after eradication in functional dyspepsia patients based on endoscopic view of antral gastropathy.
New Microbes New Infect. 2020 Nov 9;38:100806. doi: 10.1016/j.nmni.2020.100806. eCollection 2020 Nov.
本文引用的文献
1
Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled "ENTER" trial.
Am J Gastroenterol. 2006 Sep;101(9):2096-106. doi: 10.1111/j.1572-0241.2006.00751.x. Epub 2006 Jun 30.
2
The functional gastrointestinal disorders and the Rome III process.
Gastroenterology. 2006 Apr;130(5):1377-90. doi: 10.1053/j.gastro.2006.03.008.
3
Eradication of Helicobacter pylori for non-ulcer dyspepsia.
Cochrane Database Syst Rev. 2006 Apr 19(2):CD002096. doi: 10.1002/14651858.CD002096.pub4.
4
A placebo-controlled trial of itopride in functional dyspepsia.
N Engl J Med. 2006 Feb 23;354(8):832-40. doi: 10.1056/NEJMoa052639.
5
Prevalence and health/social impacts of functional dyspepsia in Taiwan: a study based on the Rome criteria questionnaire survey assisted by endoscopic exclusion among a physical check-up population.
Scand J Gastroenterol. 2005 Apr;40(4):402-11. doi: 10.1080/00365520510012190.
6
Gall-bladder dyspepsia.
Br Med J. 1963 Jul 20;2(5350):138-41. doi: 10.1136/bmj.2.5350.138.
7
Meta-analysis of dyspepsia and nonsteroidal antiinflammatory drugs.
Arthritis Rheum. 2003 Aug 15;49(4):508-18. doi: 10.1002/art.11192.
8
Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients.
Gut. 2002 Oct;51(4):502-6. doi: 10.1136/gut.51.4.502.
9
Clinical and economic consequences of dyspepsia in the community.
Gut. 2002 May;50 Suppl 4(Suppl 4):iv10-2. doi: 10.1136/gut.50.suppl_4.iv10.
10
Functional dyspepsia symptoms, gastric emptying and satiety provocative test: analysis of relationships.
Scand J Gastroenterol. 2001 Oct;36(10):1030-6. doi: 10.1080/003655201750422611.
Zotero 插件